Latest Reports

The 2025 Refractive Surgery Market Report provides a comprehensive view of the global refractive and presbyopia-correcting surgical market, highlighting the trends, drivers, and opportunities shaping the next five years. The report analyzes LASIK, lenticular extraction, phakic IOLs, refractive lens exchange (RLE), and emerging technologies poised to disrupt the market. 

It examines key participants in this segment, including prospective patients, refractive surgeons, laser centers, manufacturers of excimer and femtosecond lasers, mechanical microkeratomes, diagnostic equipment, and other presbyopia-correcting technologies.  

The report provides unit and revenue forecasts, market share analysis, and in-depth profiles of 15 leading competitors, including product portfolios, strategic positioning, company background, and outlook. 

Our coverage of the cataract surgery market includes a quarterly surveying process that targets and collects data from US cataract surgeons. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Cataract Editions. These editions are designed to improve your decision-making process with the most accurate assessment of current market conditions and the identification of significant market trends. 

Our coverage of the refractive surgery market includes a quarterly surveying process that targets and collects data from US refractive surgeons. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Refractive Editions. These editions are designed to improve your decision-making process with the most accurate assessment of current market conditions and the identification of significant market trends. 

The Ophthalmic Market Trends: Quarterly US Glaucoma Editions deliver essential, data-driven insights into the US glaucoma surgery market. These reports, based on quarterly surveys of glaucoma surgeons, provide a comprehensive analysis of key metrics such as patient diagnoses, treatment regimens, medication usage, surgical procedure volumes, and emerging trends in MIGS, canal-based procedures, and investigational treatments. With in-depth trend analysis, full-year forecasts, and year-over-year comparisons, these editions equip you with the latest information on product adoption, market share, and treatment strategies, ensuring you make informed, strategic decisions in the glaucoma treatment landscape.

Our coverage of the US retina market includes a quarterly surveying process that targets and collects data from retina specialists. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Retina Editions. These editions are designed to improve your decision-making process with an assessment of current market conditions and the identification of significant market trends -- including retinal patient care, product use and market share, product adoption plans, and doctors’ evaluations of pharmaceuticals and surgical equipment.

Each update includes full-year forecasts, comparisons with prior years, and trend analysis.

The “Ophthalmic Deals Report” analyzes recent investments in ophthalmology and provides information for evaluation of the market value of various technologies, as evidenced by investment amounts and sales prices for new ophthalmic ventures.

This report covers recent investments in ophthalmic ventures, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings. The report is designed for entrepreneurs, investors, venture capitalists, and companies looking to invest in the ophthalmic market—and companies looking to raise funds.

The “2025 Glaucoma Surgical Device Market Report” provides a data-driven analysis of the global market for glaucoma surgical devices, offering comprehensive coverage of current technologies, innovation pipelines, competitive positioning, and growth opportunities by region. 

The report examines global glaucoma prevalence and treatment trends. It details the full spectrum of commercialized devices—including microstents, subconjunctival shunts, canal surgery devices, and tube shunts—and evaluates the pipeline of investigational products that are poised to improve outcomes and drive future adoption. 

Market demand is forecast in both units and dollars through 2030, with detailed segmentation by device category, procedure type, and region. Competitive analysis includes market share estimates, plans for product adoption, and detailed profiles of 29 leading and emerging companies, highlighting their products, strategic positioning, and outlook in this rapidly evolving segment. 

The “2025 Ophthalmic Surgical Instruments Market Report” delivers a comprehensive analysis of the global market for reusable and disposable ophthalmic surgical instruments, with forecasts through 2030. This edition examines the latest market trends, technology shifts, and competitive dynamics shaping the future of ophthalmic surgery worldwide. It includes a comprehensive overview of ophthalmic procedures and surgical volumes, with a special focus on cataract surgery—the most frequently performed ophthalmic procedure globally.

Product demand is projected in both units and dollars, with detailed market share analysis across key product categories. The report profiles 29 leading competitors, exploring their products, strategic positioning, and growth outlook, while also identifying 83 companies actively participating in this market segment.

The 2025 China Ophthalmic Market Report delivers a comprehensive analysis of China’s rapidly evolving ophthalmic sector, analyzing the demographic trends and economic conditions that will shape the future of the market. The report offers deep insights into disease prevalence, highlights commercialized products and promising pipeline assets, and forecasts unit demand, sales revenue, and market performance through 2030. Competitive dynamics are thoroughly analyzed across product categories, and the report provides detailed profiles of 32 major competitors, their product portfolios, strategic positions, and future outlooks.  

Market Scope’s 2025 Glaucoma Disease Model offers extensive country-level prevalence data and five-year forecasts for glaucoma by type and by age group for all countries with a population over a million.

This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients’ diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.